As of October 2024, Suven Life Sciences has a market cap of $398.83M. This makes Suven Life Sciences the world's 12847th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $275.16M | 30.77% |
2023 | $210.41M | 17.97% |
2022 | $178.36M | -23.18% |
2021 | $232.17M | -1.60% |
2020 | $235.95M | -70.51% |
2019 | $800.21M | 35.56% |
2018 | $590.32M | 11.38% |
2017 | $530.00M | 17.64% |
2016 | $450.53M | -34.94% |
2015 | $692.47M | 26.16% |
2014 | $548.89M | 193.18% |
2013 | $187.22M | 132.52% |
2012 | $80.52M | 161.86% |
2011 | $30.75M | -52.99% |
2010 | $65.40M | -13.30% |
2009 | $75.44M | 79.26% |
2008 | $42.08M | -72.20% |
2007 | $151.39M | 585.55% |
2006 | $22.08M | 71.39% |
2005 | $12.89M | -18.63% |
2004 | $15.84M | -4.55% |
2003 | $16.59M | - |